Home › Kanser sa Pancreas › Michigan › Detroit
Pag-aaral pangklinika para sa Kanser sa Pancreas sa Detroit, MI
Isang pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Detroit. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Nagre-recruitPhase 3
- Investigative Site US010, Detroit
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Nagre-recruitObservasyonal na pag-aaral
- Henry Ford Health Saint John Hospital, Detroit
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Nagre-recruitPhase 1
- Karmanos Cancer Institute, Detroit
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Nagre-recruitPhase 3
- Henry Ford Hospital, Detroit
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
Nagre-recruitPhase 1/2
- Karmanos Cancer Institute, Detroit
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Nagre-recruitPhase 2
- Karmanos Cancer Center, Detroit
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Nagre-recruitPhase 2
- Henry Ford Centre, Detroit
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Nagre-recruitPhase 1/2
- Karmanos Cancer Institute, Detroit
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Nagre-recruitPhase 2
- Ohio State University-Telemedicine, Detroit
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Nagre-recruitPhase 1
- Henry Ford Cancer-Detroit, Detroit
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Nagre-recruitPhase 2/3
- Henry Ford Health System, Detroit
Pag-aaral para sa Kanser sa Pancreas sa ibang lungsod
- Houston, TX61 pag-aaral
- New York City, NY60 pag-aaral
- Boston, MA43 pag-aaral
- Nashville, TN39 pag-aaral
- Los Angeles, CA35 pag-aaral
- St. Louis, MO33 pag-aaral
- Arlington, VA33 pag-aaral
- Baltimore, MD31 pag-aaral
- San Antonio, TX31 pag-aaral
- Philadelphia, PA26 pag-aaral
- Tampa, FL26 pag-aaral
- Durham, NC24 pag-aaral
Iba pang pag-aaral sa Detroit
- Non-Small Cell Lung Cancer44 pag-aaral
- Kanser sa Suso33 pag-aaral
- Kanser (lahat ng uri)29 pag-aaral
- Colorectal Cancer26 pag-aaral
- Kanser sa Ovary26 pag-aaral
- Metastatic Cancer24 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser ng Endometrium21 pag-aaral
- Kanser sa Baga20 pag-aaral
- Multiple Myeloma19 pag-aaral
- Kanser sa Tiyan16 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.